We are live on ! Find out more
KALA icon

KALA BIO
KALA

21 hedge funds and large institutions have $3.68M invested in KALA BIO in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 20 → 21 (+1)

0.68% less ownership

Funds ownership: 20.22% → 19.55% (-0.68%)

19% less capital invested

Capital invested by funds: $4.57M → $3.68M (-$891K)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$99.8K
2
TRCT
Tower Research Capital (TRC)
New York
+$30.8K
3
Bank of America
Bank of America
North Carolina
+$17.7K
4
KOCAA
Knights of Columbus Asset Advisors
Connecticut
+$17.3K
5
BlackRock
BlackRock
New York
+$8.49K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$108K
2
Millennium Management
Millennium Management
New York
-$12K
3
C
Covestor
United Kingdom
-$708
4
Morgan Stanley
Morgan Stanley
New York
-$354
5
PFBT
Parkside Financial Bank & Trust
Missouri
-$339

KALA Hedge Fund Activity: Q4 2023 in Review

21 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2023, worth a combined $3.68M — down 19% from $4.57M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new KALA positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $99.8K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $108K sold.

  • 21 institutional investors held KALA BIO (KALA) as of Q4 2023, up from 20 in Q3 2023.
  • Funds reported $3.68M of KALA BIO stock for Q4 2023, down 19% quarter-over-quarter.
  • 3 funds opened new KALA BIO positions in Q4 2023 and 2 closed out, a net change of +1 holder.
  • The largest KALA BIO buyer in Q4 2023 was Renaissance Technologies, an estimated $99.8K added.
  • The largest KALA BIO seller in Q4 2023 was Dimensional Fund Advisors, an estimated $108K sold.

Based on aggregated 13F filings for Q4 2023.